Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPL DE MEDECIN Q. LANDOLFF : revenue, balance sheet and financial ratios

SPFPL DE MEDECIN Q. LANDOLFF is a French company founded 2 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in ROUEN (76000), this company of category PME shows in 2025 a net income positive of 103 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL DE MEDECIN Q. LANDOLFF (SIREN 979779113)
Indicator 2025 2024
Revenue N/C N/C
Net income 102 522 € 195 216 €
EBITDA -8 483 € -25 750 €
Net margin N/C N/C

Revenue and income statement

In 2025, SPFPL DE MEDECIN Q. LANDOLFF generates positive net income of 103 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2024-2025: 195 k€ -> 103 k€.

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-8 483 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-8 483 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

102 522 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 112%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 3.3 years of cash flow to repay all financial debt. This ratio remains within usual banking standards.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

111.951%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

47.074%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

3.262

Solvency indicators evolution
SPFPL DE MEDECIN Q. LANDOLFF

Sector positioning

Debt ratio
111.95 2025
2024
2025
Q1: 0.14
Med: 27.24
Q3: 146.28
Average -7 pts over 2 years

In 2025, the debt ratio of SPFPL DE MEDECIN Q. LANDOLFF (111.95) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
47.07% 2025
2024
2025
Q1: 17.38%
Med: 54.75%
Q3: 87.41%
Average +6 pts over 2 years

In 2025, the financial autonomy of SPFPL DE MEDECIN Q. LANDOLFF (47.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
3.26 years 2025
2024
2025
Q1: 0.0 years
Med: 0.77 years
Q3: 6.12 years
Average

In 2025, the repayment capacity of SPFPL DE MEDECIN Q. LANDOLFF (3.26) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 9057.50. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

9057.5

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-126.913

Liquidity indicators evolution
SPFPL DE MEDECIN Q. LANDOLFF

Sector positioning

Liquidity ratio
9057.5 2025
2024
2025
Q1: 159.67
Med: 1116.63
Q3: 6512.12
Excellent

In 2025, the liquidity ratio of SPFPL DE MEDECIN Q. LANDOLFF (9057.50) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
-126.91x 2025
2024
2025
Q1: -191.54x
Med: -25.42x
Q3: 0.0x
Average -15 pts over 2 years

In 2025, the interest coverage of SPFPL DE MEDECIN Q. LANDOLFF (-126.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Positioning of SPFPL DE MEDECIN Q. LANDOLFF in its sector

Comparison with sector Fonds de placement et entités financières similaires

Valuation estimate

Based on 170 transactions of similar company sales (all years), the value of SPFPL DE MEDECIN Q. LANDOLFF is estimated at 1 062 825 € (range 658 797€ - 1 653 027€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
170 transactions
658k€ 1062k€ 1653k€
1 062 825 € Range: 658 797€ - 1 653 027€
NAF 5 all-time

Valuation method used

Net Income Multiple
102 522 € × 10.4x = 1 062 825 €
Range: 658 797€ - 1 653 028€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 170 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fonds de placement et entités financières similaires)

Compare SPFPL DE MEDECIN Q. LANDOLFF with other companies in the same sector:

Frequently asked questions about SPFPL DE MEDECIN Q. LANDOLFF

What is the revenue of SPFPL DE MEDECIN Q. LANDOLFF ?

The revenue of SPFPL DE MEDECIN Q. LANDOLFF is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPL DE MEDECIN Q. LANDOLFF profitable?

Yes, SPFPL DE MEDECIN Q. LANDOLFF generated a net profit of 103 k€ in 2025.

Where is the headquarters of SPFPL DE MEDECIN Q. LANDOLFF ?

The headquarters of SPFPL DE MEDECIN Q. LANDOLFF is located in ROUEN (76000), in the department Seine-Maritime.

Where to find the tax return of SPFPL DE MEDECIN Q. LANDOLFF ?

The tax return of SPFPL DE MEDECIN Q. LANDOLFF is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL DE MEDECIN Q. LANDOLFF operate?

SPFPL DE MEDECIN Q. LANDOLFF operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.